The XTRAC Laser Delivers Real Results
Today, thousands of patients in the United States as well as internationally have benefited from treatment with the XTRAC laser. Numerous clinical studies have shown the dramatic difference that 308nm laser light can make in enhancing patient outcomes, reducing diseased areas and improving quality of life.
Introduced in 2000, the XTRAC is the first FDA market-cleared excimer laser system for the treatment of psoriasis. It is also cleared for treatment of vitiligo and atopic dermatitis.
Using a carefully focused beam of light delivered through a sophisticated liquid light guide device, the XTRAC system allows the physician to use the high dose of monochromatic UVB right to the spot of the problem for fast, effective treatment while minimizing the risk of exposure to healthy skin.